AU1437695A - Monoclonal antibodies against hev orf-2 and methods for using same - Google Patents
Monoclonal antibodies against hev orf-2 and methods for using sameInfo
- Publication number
- AU1437695A AU1437695A AU14376/95A AU1437695A AU1437695A AU 1437695 A AU1437695 A AU 1437695A AU 14376/95 A AU14376/95 A AU 14376/95A AU 1437695 A AU1437695 A AU 1437695A AU 1437695 A AU1437695 A AU 1437695A
- Authority
- AU
- Australia
- Prior art keywords
- methods
- same
- monoclonal antibodies
- antibodies against
- against hev
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17194893A | 1993-12-22 | 1993-12-22 | |
US171948 | 1993-12-22 | ||
PCT/US1994/014505 WO1995017501A1 (en) | 1993-12-22 | 1994-12-16 | Monoclonal antibodies against hev orf-2 and methods for using same |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1437695A true AU1437695A (en) | 1995-07-10 |
Family
ID=22625753
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU14376/95A Abandoned AU1437695A (en) | 1993-12-22 | 1994-12-16 | Monoclonal antibodies against hev orf-2 and methods for using same |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0736087A1 (en) |
JP (1) | JPH09507025A (en) |
AU (1) | AU1437695A (en) |
CA (1) | CA2179609A1 (en) |
WO (1) | WO1995017501A1 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6787145B1 (en) | 1992-09-18 | 2004-09-07 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
ATE449178T1 (en) | 1992-09-18 | 2009-12-15 | Us Gov Health & Human Serv | RECOMBINANT PROTEINS OF A PAKISTANI STRAIN OF HEPATITIS E VIRUS AND THEIR USE IN DIAGNOSTIC PROCEDURES AND AS A VACCINE |
US6207416B1 (en) | 1992-09-18 | 2001-03-27 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
EP0784631B1 (en) * | 1994-10-03 | 2011-08-03 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Method of producing a partial orf2 protein of hepatitis e virus |
US6054567A (en) * | 1997-04-11 | 2000-04-25 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
US6458562B1 (en) | 1998-04-09 | 2002-10-01 | The United States Of America As Represented By The Secretary Of Health And Human Services | Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
CN101367869B (en) | 2000-09-30 | 2012-12-05 | 北京万泰生物药业股份有限公司 | Polypeptide for preventing, diagnosing and treating hepatitis E virus, and vaccine as diagnosis agent of the same |
AU2002349727B2 (en) | 2001-11-08 | 2008-10-16 | Beijing Wantai Biological Pharmacy Enterprise Co., Ltd | Hepatitis E virus monoclonal antibodies or the binding fragments of it and the use thereof |
WO2023174976A1 (en) | 2022-03-16 | 2023-09-21 | Universität Zu Lübeck | Broadly neutralizing antibodies against hepatitis e virus |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU632271B2 (en) * | 1988-03-30 | 1992-12-24 | Abbott Laboratories | Production of monoclonal antibodies specific for non-a, non-b hepatitis infected liver |
US6455492B1 (en) * | 1988-06-17 | 2002-09-24 | Genelabs Technologies, Inc. | Hepatitis E virus vaccine and method |
US5885768A (en) * | 1988-06-17 | 1999-03-23 | The United States Of America As Represented By The Department Of Health And Human Services | Hepatitis E virus peptide antigen and antibodies |
-
1994
- 1994-12-16 CA CA002179609A patent/CA2179609A1/en not_active Abandoned
- 1994-12-16 AU AU14376/95A patent/AU1437695A/en not_active Abandoned
- 1994-12-16 WO PCT/US1994/014505 patent/WO1995017501A1/en not_active Application Discontinuation
- 1994-12-16 EP EP95905967A patent/EP0736087A1/en not_active Withdrawn
- 1994-12-16 JP JP7517515A patent/JPH09507025A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP0736087A1 (en) | 1996-10-09 |
JPH09507025A (en) | 1997-07-15 |
CA2179609A1 (en) | 1995-06-29 |
WO1995017501A1 (en) | 1995-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4042195A (en) | Anti-alphaV-integrin monoclonal antibody | |
AU5869596A (en) | Anti-gp130 monoclonal antibodies | |
AU1432195A (en) | Process for generating specific antibodies | |
HU9601574D0 (en) | Humanized antibodies and uses thereof | |
AU1183295A (en) | Immunoassays employing generic anti-hapten antibodies and materials for use therein | |
AU1289795A (en) | Monoclonal antibodies specific for human interleukin-5 | |
IL109159A (en) | Immunoassays for tetrachloroiso-phthalonitrile and its metabolites and antibodies for use therein | |
AU7041996A (en) | Antibody specific for beta1->6N- acetylglucosamininyltransferase | |
AU666605B2 (en) | Reagent for endotoxin assay and method for endotoxin assay using the same | |
AU5611394A (en) | Antibodies for gm-csf receptor and uses thereof | |
AU6080794A (en) | Antibodies directed against binding-associated epitopes | |
AU7422496A (en) | NM03 antibody materials and methods | |
GB9412166D0 (en) | Retargetting antibodies | |
AU2645297A (en) | Hepatitis b monoclonal antibodies | |
AU2097592A (en) | Fibrinogen-specific monoclonal antibody and uses thereof | |
AU3330689A (en) | Monoclonal antibodies | |
AU7203194A (en) | Bispecific human monoclonal antibodies specific for human immunodeficiency virus | |
AU1437695A (en) | Monoclonal antibodies against hev orf-2 and methods for using same | |
AU2696495A (en) | Method for determining hiv-1 antigen and antibody | |
EP0909278A4 (en) | Nephropathy-related immunoglobulin g and antibodies for same | |
AU4256096A (en) | Monoclonal antibody fragments having immunosuppressant activity | |
AU4450389A (en) | Anti-fucosylcermiade monoclonal antibody | |
AU7858691A (en) | Plaque-inhibiting protein from bacteroides loeschei and methods for using the same | |
AU6681494A (en) | Immunoparticles bearing monoclonal anti-cd4 antibodies and utilisation thereof | |
GB2309522B (en) | An immunoassay for fungal antigens |